Hunan Fangsheng Pharmaceutical Co., Ltd. (SHA:603998)

SHA:603998 Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Sep 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	195.45	208.98	399.72	258.88	318.85	156.12
Short-Term Investments	-	-	-	-	-	30
Trading Asset Securities	16.52	20.33	40.31	15.42	0.3	0.29
Cash & Short-Term Investments	211.97	229.3	440.03	274.3	319.15	186.41
Cash Growth	-1.64%	-47.89%	60.42%	-14.05%	71.20%	-41.42%
Accounts Receivable	310.99	231.09	191.95	254.67	205.36	176.06
Other Receivables	48.76	13.5	164.9	30.2	19.63	27.11
Receivables	359.75	244.59	356.85	284.87	224.99	203.16
Inventory	384.1	328.28	303.4	256.73	209.78	206.51
Prepaid Expenses	-	-	-	-	-	3.05
Other Current Assets	88.93	118.49	90.81	50.74	41.78	45.81
Total Current Assets	1,045	920.67	1,191	866.63	795.69	644.94
Property, Plant & Equipment	1,176	1,051	841.25	823.03	657.05	601.41
Long-Term Investments	241.44	257.52	252.97	193.91	139.8	120.93
Goodwill	274.41	274.41	246.44	378.73	250.9	252.13
Other Intangible Assets	254.15	267.68	273.71	249.95	227.04	242.55
Long-Term Accounts Receivable	-	149.23	26.38	42.39	45.79	46.79
Long-Term Deferred Tax Assets	13.82	15.6	4.24	1.53	1.36	1.1
Long-Term Deferred Charges	15.61	18.13	8.06	41.09	43.01	36.25
Other Long-Term Assets	266.28	126.44	78.27	107.21	82.14	48.84
Total Assets	3,286	3,081	2,922	2,704	2,243	1,995
Accounts Payable	270.16	245.82	165.61	117.18	103.5	94.87
Accrued Expenses	32.75	297.49	311.88	272.16	218.52	189.62
Short-Term Debt	541.16	309.27	229.96	462.95	412.22	278.5
Current Portion of Long-Term Debt	49.67	193.88	20.11	13.85	5.25	-
Current Portion of Leases	-	2.35	0.49	10.46	-	-
Current Income Taxes Payable	24.59	10.05	25.06	9.89	2.99	2.03
Current Unearned Revenue	23.62	38.98	87.47	35.1	26.29	24.43
Other Current Liabilities	452.95	150.24	159.02	333.87	107.75	99.7
Total Current Liabilities	1,395	1,248	999.59	1,255	876.54	689.14
Long-Term Debt	97.78	155.11	342.89	27.75	25.26	30.28
Long-Term Leases	19.56	21.31	0.84	37.04	-	-
Long-Term Unearned Revenue	30.44	32.86	37.22	53.41	57.95	56.51
Long-Term Deferred Tax Liabilities	32.12	34.51	33.92	27.17	17.3	16.57
Other Long-Term Liabilities	-	0.38	-	-	-	-
Total Liabilities	1,575	1,492	1,414	1,401	977.05	792.51
Common Stock	439.12	439.73	439.31	429.43	429.43	434.46
Additional Paid-In Capital	188.91	185.82	163.87	131.93	131.93	142.39
Retained Earnings	968.21	849.61	816.65	634.76	590.48	578.09
Treasury Stock	-1.12	-17	-29.63	-	-	-28.03
Comprehensive Income & Other	-0.07	-0.07	-0.07	-0.07	-0.1	-
Total Common Equity	1,595	1,458	1,390	1,196	1,152	1,127
Minority Interest	116.32	130.63	117.81	107.6	113.99	75.53
Shareholders' Equity	1,711	1,589	1,508	1,304	1,266	1,202
Total Liabilities & Equity	3,286	3,081	2,922	2,704	2,243	1,995
Total Debt	708.16	681.93	594.3	552.05	442.74	308.78
Net Cash (Debt)	-496.19	-452.62	-154.26	-277.75	-123.59	-122.37
Net Cash Per Share	-1.10	-1.02	-0.36	-0.63	-0.29	-0.28
Filing Date Shares Outstanding	439.12	439.73	439.31	429.43	429.43	434.46
Total Common Shares Outstanding	439.12	439.73	439.31	429.43	429.43	434.46
Working Capital	-350.15	-327.42	191.5	-388.83	-80.85	-44.2
Book Value Per Share	3.63	3.32	3.16	2.79	2.68	2.59
Tangible Book Value	1,066	916.01	869.98	567.36	673.8	632.23
Tangible Book Value Per Share	2.43	2.08	1.98	1.32	1.57	1.46
Buildings	-	774.18	635.14	529.35	496.37	445.62
Machinery	-	384.19	309.4	362.11	301.52	268.34
Construction In Progress	-	217.53	189.65	201.99	121.88	97.2

Source: S&P Global Market Intelligence. Standard template. Financial Sources.